tiprankstipranks
Trending News
More News >

Bio-Techne price target lowered to $65 from $90 at Argus

Argus lowered the firm’s price target on Bio-Techne (TECH) to $65 from $90 but keeps a Buy rating on the shares. Bio-Techne’s endmarkets have improved, but it now faces multiple headwinds in the form of trade tariffs and cuts in funding to academic and government customers, the analyst tells investors in a research note. Given the changing dynamics for tariffs and NIH funding however, these headwinds may well be temporary and the improving end markets may be more sustainable, the firm added.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue